Latest Chemicals News

PT ANTAM (ASX:ATM) posted a 12% rise in gold production in 2Q26 and advanced key downstream projects including EV battery ecosystem development, while securing multiple ESG awards.

Impact Minerals pushes its Lake Hope High Purity Alumina project into pilot production while its JV partner Kuniko hits mineralisation in every hole at Commonwealth, discovering new high-grade extensions.

Vanadium Resources pivots to a co-production V-Iron Plant at Steelpoortdrift, securing a non-binding offtake with US Vanadium and appointing Rand Merchant Bank to drive project financing.

Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.

Talga Group has marked a milestone with its first commercial delivery of natural graphite anode outside Asia, progressing key funding discussions and strategic partnerships to support its Vittangi Anode Project.

Quantum Graphite has cemented a two-decade exclusive ore supply agreement with Sunlands Pure Group, consolidating its downstream processing and refining operations. The company also secured environmental approvals for Sunlands Pure’s Oman refinery and kicked off detailed engineering for its Uley 2 project.

NOVONIX has hit a critical milestone by delivering a synthetic graphite anode sample to Panasonic, supporting a planned production start in late 2027. The company secured A$21.66 million in fresh capital to fund production readiness, while navigating an evolving US trade and policy landscape aimed at boosting domestic battery materials.

Patagonia Lithium (ASX:PL3) reported solid progress in its June quarter, hitting key milestones in drilling, pump testing, and resource modelling at its Argentine lithium brine projects, supported by a strong cash position following recent capital raises.

Parkway Corporate delivered a record $7.25 million quarterly revenue and $0.54 million EBITDA, powered by a major water infrastructure contract. The company progressed key approvals for its Queensland Brine Management Complex and struck a strategic collaboration with Hitachi to develop advanced brine concentration technology.

PLS Group Limited delivered record FY26 lithium production and sales, boosted revenue 152%, and commenced Ngungaju plant restart, setting the stage for growth with P2000 expansion feasibility underway.

De.mem Limited posted its second highest quarterly cash receipts of approximately $9.6 million for June 2026, marking 29 consecutive quarters of growth and positive operating cash flow of $424k. The company’s strong half-year performance is underpinned by recurring revenues, a robust Western Australian business, and record results from its German subsidiary.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.